US breast cancer mortality trends in young women according to race

Cancer

Volumn 121, Issue 9, 2015, Pages 1469-1476

  Ademuyiwa, Foluso O ^a   Gao, Feng ^a   Hao, Lin ^b   Morgensztern, Daniel ^a   Aft, Rebecca L ^a   Ma, Cynthia X ^a   Ellis, Matthew J ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Mary's Health Center   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

breast cancer; survival; trends; young age

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RACE DIFFERENCE; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; TUMOR INVASION; UNITED STATES; AFRICAN AMERICAN; BREAST TUMOR; CANCER REGISTRY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; KAPLAN MEIER METHOD; LUNG CARCINOMA; MORTALITY; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; SEER PROGRAM; UNITED STATES;

EID: 84928295427     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29178     Document Type: Article

References (34)

1. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B,; Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8: 288-298.
2. American Cancer Society. Breast Cancer Facts & Figures 2013-2014. Atlanta, GA: American Cancer Society; 2013.
3. Gabriel CA, Domchek SM,. Breast cancer in young women. Breast Cancer Res. 2010; 12: 212.
4. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008; 26: 3324-3330.
5. de la Rochefordiere A, Asselain B, Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993; 341: 1039-1043.
6. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA,. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009; 208: 341-347.
7. El Saghir NS, Seoud M, Khalil MK, et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer. 2006; 6: 194.
8. Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003; 14: 151-160.
9. Hall IJ, Moorman PG, Millikan RC, Newman B,. Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol. 2005; 161: 40-51.
10. Shavers VL, Harlan LC, Stevens JL,. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134-147.
11. Elledge RM, Clark GM, Chamness GC, Osborne CK,. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705-712.
12. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institute; 2012. seer.cancer.gov/csr/1975-2009-pops09/index.html. Accessed April 19, 2012.
13. Muller HG, Wang JL,. Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics. 1994; 50: 61-76.
14. Newman LA, Bunner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer. 2002; 95: 21-27.
15. Freedman RA, Hughes ME, Ottesen RA, et al. Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 2013; 119: 839-846.
16. Reeder-Hayes KE, Meyer AM, B, Dusetzina S, Liu H, Wheeler SB,. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat. 2014; 145: 743-751.
17. Lipscomb J, Gillespie TW, Goodman M, et al. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat. 2012; 133: 285-296.
18. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947-954.
19. Heimann R, Ferguson D, Powers C, Suri D, Weichselbaum RR, Hellman S,. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997; 15: 2329-2337.
20. Shi R, Mills G, McLarty J, Burton G, Shi Z, Glass J,. Commercial insurance triples chances of breast cancer survival in a public hospital. Breast J. 2013; 19: 664-667.
21. Dignam JJ,. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr. 2001;(30): 36-43.
22. Menashe I, Anderson WF, Jatoi I, Rosenberg PS,. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009; 101: 993-1000.
23. Quan L, Gong Z, Yao S, et al. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. Int J Cancer. 2014; 134: 1408-1421.
24. Gong Z, Quan L, Yao S, et al. Innate immunity pathways and breast cancer risk in African American and European-American women in the Women's Circle of Health Study (WCHS). PLoS One. 2013; 8: e72619.
25. Murray JL, Thompson P, Yoo SY, et al. Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast Cancer Res Treat. 2013; 138: 917-924.
26. Ademuyiwa FO, Olopade OI,. Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev. 2003; 22: 47-53.
27. Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL,. Early onset of breast cancer in a group of British black women. Br J Cancer. 2008; 98: 277-281.
28. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009; 27: 4515-4521.
29. Copson E, Eccles B, Maishman T, et al. POSH Study Steering Group. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013; 105: 978-988.
30. Ademuyiwa FO, Groman A, Hong CC, et al. Time-trends in survival in young women with breast cancer in a SEER population-based study. Breast Cancer Res Treat. 2013; 138: 241-248.
31. Johnson RH, Chien FL, Bleyer A,. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013; 309: 800-805.
32. Bouchardy C, Fioretta G, Verkooijen HM, et al. Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer. 2007; 96: 1743-1746.
33. Krieger N, Chen JT, Ware JH, Kaddour A,. Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control. 2008; 19: 1305-1318.
34. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 10869-10874.